Report

reporttype1Version of Safety Report ID1receivedateformat102transmissiondateformat102fulfillexpeditecriteria1Safety Report ID10078488serious1Date Last Updated15/04/2014receiptdateformat102companynumbGB-DRREDDYS-GER/UKI/14/0039634occurcountryGBseriousnessother1duplicate1seriousnesscongenitalanomali1Date Received15/04/2014transmissiondate12/12/2014primarysourcecountryGB

Primary Source

reportercountryGBqualification1

Patient

SexUnknown

Contents

Reaction
- 1)
- 2)
- 3)
- 4)
- 5)
Drug

Reaction

1)

reactionmeddraversionpt17.0ReactionAnencephalyOutcomeNot recovered/not resolved

2)

reactionmeddraversionpt17.0ReactionCraniorachischisisOutcomeNot recovered/not resolved

3)

reactionmeddraversionpt17.0ReactionCystic lymphangiomaOutcomeNot recovered/not resolved

4)

reactionmeddraversionpt17.0ReactionTeratogenicityOutcomeNot recovered/not resolved

5)

reactionmeddraversionpt17.0ReactionFoetal exposure during pregnancyOutcomeUnknown

Drug

1)

drugcharacterization1medicinalproductSERTRALINEdrugbatchnumbUNKNOWNdrugstructuredosagenumb150drugstructuredosageunit003drugadministrationroute064drugindicationPRODUCT USED FOR UNKNOWN INDICATIONdrugrecurreadministration3

openFDA Info on Medication

Application NumberANDA077670, ANDA077864, ANDA077397Brand NameSERTRALINEGeneric NameSERTRALINE, SERTRALINE HYDROCHLORIDEManufacturers Lupin Pharmaceuticals, Inc., Hikma Pharmaceuticals USA Inc., Exelan Pharmaceutic ... product_ndc 68180-351, 68180-352, 68180-353, 0143-9655, 0143-9656, 0143-9654, 76282-212, 762 ... Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSERTRALINE HYDROCHLORIDERXCUI312938, 312940, 312941spl_id 78d3579a-260f-4bb2-95f2-8ee8a60fae18, f35de481-61af-428e-abb4-a267238b3959, 5c8d ... spl_set_id 42120ff8-b353-4632-9ea9-54de9a698724, f9641190-9151-4f7e-89ff-1e7a818c30ee, 2dac ... Package NDC 68180-351-06, 68180-351-08, 68180-351-09, 68180-351-01, 68180-351-03, 68180-352- ... UNIIUTI8907Y6X

2)

drugcharacterization2medicinalproductTHYROXINEdrugstructuredosagenumb150drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugadministrationroute064drugindicationPRODUCT USED FOR UNKNOWN INDICATIONdrugenddateformat102drugenddate07/02/2014

Report Duplicate

duplicatesourceDR REDDYSduplicatenumbGB-DRREDDYS-GER/UKI/14/0039634

Receiver

receivertype6receiverorganizationFDA

Sender

sendertype2senderorganizationFDA-Public Use

Adverse Event Report

Report

Primary Source

Patient

Reaction

1)

2)

3)

4)

5)

Drug

1)

openFDA Info on Medication

2)

Report Duplicate

Receiver

Sender

Media

Newsletter

Follow us

Connect with us